基本信息
views: 186
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
主要围绕YAP/TAZ等致癌转录因子的调控机制及干预策略展开研究,旨在发现基于转录因子调控的抗肿瘤新靶点和候选新药。近年以第一或通讯作者身份在Hepatology、Cancer Research、JMC、APSB等期刊发表SCI论文30余篇,总他引次数2000余次。先后主持国家自然科学基金面上项目、国家重大新药创制候选新药项目等国家级课题8项,浙江省重点研发计划、浙江省杰青项目等省部级项目4项。相关研究成果获浙江省自然科学一等奖、教育部自然科学二等奖等奖励6项。授权中国发明专利5项,参与获得抗肿瘤1类新药临床批件2项。兼任中国抗癌协会抗癌药物专委会委员、浙江省抗癌协会抗癌药物专委会委员、浙江省生化与分子生物学学会理事等职。
Research Interests
Papers共 390 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
CANCER IMMUNOLOGY RESEARCHno. 2 (2024): 275-275
Acta Pharmaceutica Sinica Bno. 4 (2024): 1508-1524
Xuhong Zhang,Xiaoyu Wang,Yanqing Li, Yingying Zhang,Hong Zhu,Chen Xie,Yudong Zhou,Ye Shen,Jianping Tong
Cellular and Molecular Neurobiologyno. 1 (2024): 19-19
Fu-jing Ge,Xiao-yang Dai,Yao Qiu, Xiang-ning Liu,Chen-ming Zeng, Xiao-yuan Xu,Yi-dan Chen,Hong Zhu,Qiao-jun He,Ren-hua Gai,Sheng-lin Ma,Xue-qin Chen,
Acta Pharmacologica Sinicano. 6 (2024): 1-12
Plant Communicationsno. 4 (2024): 100834-100834
CRITICAL REVIEWS IN PLANT SCIENCESno. 1 (2024): 34-48
Fujing Ge,Chenming Zeng, Jiaer Wang, Xiangning Liu,Churun Zheng,Hongyu Zhang,Liu Yang,Bo Yang,Hong Zhu,Qiaojun He
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASEno. 1 (2024)
Huijun Gao, Feiyan Li,Xi Chen, Ziming You, Lei Wei,Yuanlong Liu, Ping Liu,Mingyang He,Min Hong,Hong Zhu,Xuewu Duan,Yueming Jiang,
Food Chemistry (2024): 139694-139694
PLANT AND CELL PHYSIOLOGYno. 1 (2024): 49-67
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn